These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 38134886)

  • 41. High-Throughput Gene Mutagenesis Screening Using Base Editing.
    Després PC; Dubé AK; Yachie N; Landry CR
    Methods Mol Biol; 2022; 2477():331-348. PubMed ID: 35524126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.
    Anzalone AV; Koblan LW; Liu DR
    Nat Biotechnol; 2020 Jul; 38(7):824-844. PubMed ID: 32572269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Massively parallel base editing to map variant effects in human hematopoiesis.
    Martin-Rufino JD; Castano N; Pang M; Grody EI; Joubran S; Caulier A; Wahlster L; Li T; Qiu X; Riera-Escandell AM; Newby GA; Al'Khafaji A; Chaudhary S; Black S; Weng C; Munson G; Liu DR; Wlodarski MW; Sims K; Oakley JH; Fasano RM; Xavier RJ; Lander ES; Klein DE; Sankaran VG
    Cell; 2023 May; 186(11):2456-2474.e24. PubMed ID: 37137305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The potential of CRISPR-Cas9 prime editing for cardiovascular disease research and therapy.
    Bharucha N; Arias A; Karakikes I
    Curr Opin Cardiol; 2022 Sep; 37(5):413-418. PubMed ID: 35880456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Challenges and progress in interpretation of non-coding genetic variants associated with human disease.
    Zhu Y; Tazearslan C; Suh Y
    Exp Biol Med (Maywood); 2017 Jul; 242(13):1325-1334. PubMed ID: 28581336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimized high-throughput screening of non-coding variants identified from genome-wide association studies.
    Morova T; Ding Y; Huang CF; Sar F; Schwarz T; Giambartolomei C; Baca SC; Grishin D; Hach F; Gusev A; Freedman ML; Pasaniuc B; Lack NA
    Nucleic Acids Res; 2023 Feb; 51(3):e18. PubMed ID: 36546757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Annotation of functional variation in personal genomes using RegulomeDB.
    Boyle AP; Hong EL; Hariharan M; Cheng Y; Schaub MA; Kasowski M; Karczewski KJ; Park J; Hitz BC; Weng S; Cherry JM; Snyder M
    Genome Res; 2012 Sep; 22(9):1790-7. PubMed ID: 22955989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breakthrough in CRISPR/Cas system: Current and future directions and challenges.
    Ali A; Zafar MM; Farooq Z; Ahmed SR; Ijaz A; Anwar Z; Abbas H; Tariq MS; Tariq H; Mustafa M; Bajwa MH; Shaukat F; Razzaq A; Maozhi R
    Biotechnol J; 2023 Aug; 18(8):e2200642. PubMed ID: 37166088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.
    Dong W; Kantor B
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analyzing the functional effects of DNA variants with gene editing.
    Cooper S; Obolenski S; Waters AJ; Bassett AR; Coelho MA
    Cell Rep Methods; 2024 May; 4(5):100776. PubMed ID: 38744287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-coding genetic variants in human disease.
    Zhang F; Lupski JR
    Hum Mol Genet; 2015 Oct; 24(R1):R102-10. PubMed ID: 26152199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox.
    Koonin EV; Gootenberg JS; Abudayyeh OO
    Biochemistry; 2023 Dec; 62(24):3465-3487. PubMed ID: 37192099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved prime editing allows for routine predictable gene editing in Physcomitrium patens.
    Perroud PF; Guyon-Debast A; Casacuberta JM; Paul W; Pichon JP; Comeau D; Nogué F
    J Exp Bot; 2023 Oct; 74(19):6176-6187. PubMed ID: 37243510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current advances in overcoming obstacles of CRISPR/Cas9 off-target genome editing.
    Aquino-Jarquin G
    Mol Genet Metab; 2021; 134(1-2):77-86. PubMed ID: 34391646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A selectable all-in-one CRISPR prime editing piggyBac transposon allows for highly efficient gene editing in human cell lines.
    Eggenschwiler R; Gschwendtberger T; Felski C; Jahn C; Langer F; Sterneckert J; Hermann A; Lühmann J; Steinemann D; Haase A; Martin U; Petri S; Cantz T
    Sci Rep; 2021 Nov; 11(1):22154. PubMed ID: 34773059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of Functional Variants in the FAM13A Chronic Obstructive Pulmonary Disease Genome-Wide Association Study Locus by Massively Parallel Reporter Assays.
    Castaldi PJ; Guo F; Qiao D; Du F; Naing ZZC; Li Y; Pham B; Mikkelsen TS; Cho MH; Silverman EK; Zhou X
    Am J Respir Crit Care Med; 2019 Jan; 199(1):52-61. PubMed ID: 30079747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Precision genome editing in plants using gene targeting and prime editing: existing and emerging strategies.
    Hassan MM; Yuan G; Liu Y; Alam M; Eckert CA; Tuskan GA; Golz JF; Yang X
    Biotechnol J; 2022 Oct; 17(10):e2100673. PubMed ID: 35766313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. iCSDB: an integrated database of CRISPR screens.
    Choi A; Jang I; Han H; Kim MS; Choi J; Lee J; Cho SY; Jun Y; Lee C; Kim J; Lee B; Lee S
    Nucleic Acids Res; 2021 Jan; 49(D1):D956-D961. PubMed ID: 33137185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo application of base and prime editing to treat inherited retinal diseases.
    Jo DH; Bae S; Kim HH; Kim JS; Kim JH
    Prog Retin Eye Res; 2023 May; 94():101132. PubMed ID: 36241547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.